TY - JOUR AU - Hogg, R. S. AU - Yip, B. AU - Kully, C. AU - Craib, K. J. AU - O'Shaughnessy, M. V. AU - Schechter, M. T. PY - 1999 DA - 1999// TI - Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens JO - JAMA. VL - 160 ID - Hogg1999 ER - TY - JOUR AU - Egger, M. AU - May, M. AU - Chene, G. AU - Phillips, A. N. AU - Ledergerber, B. AU - Dabis, F. PY - 2002 DA - 2002// TI - Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies JO - Lancet. VL - 360 UR - https://doi.org/10.1016/S0140-6736(02)09411-4 DO - 10.1016/S0140-6736(02)09411-4 ID - Egger2002 ER - TY - JOUR AU - Palella, F. J. AU - Delaney, K. M. AU - Moorman, A. C. AU - Loveless, M. O. AU - Fuhrer, J. AU - Satten, G. A. PY - 1998 DA - 1998// TI - Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators JO - N Engl J Med VL - 338 UR - https://doi.org/10.1056/NEJM199803263381301 DO - 10.1056/NEJM199803263381301 ID - Palella1998 ER - TY - JOUR AU - Wood, E. AU - Hogg, R. S. AU - Yip, B. AU - Quercia, R. AU - Harrigan, P. R. AU - O'Shaughnessy, M. V. PY - 2003 DA - 2003// TI - Higher baseline levels of plasma human immunodeficiency virus type 1 RNA are associated with increased mortality after initiation of triple-drug antiretroviral therapy JO - J Infect Dis VL - 188 UR - https://doi.org/10.1086/379201 DO - 10.1086/379201 ID - Wood2003 ER - TY - JOUR AU - Wood, E. AU - Hogg, R. S. AU - Yip, B. AU - Harrigan, P. R. AU - Montaner, J. S. PY - 2005 DA - 2005// TI - Why are baseline HIV RNA levels 100,000 copies/mL or greater associated with mortality after the initiation of antiretroviral therapy? JO - J Acquir Immune Defic Syndr VL - 38 ID - Wood2005 ER - TY - JOUR AU - Wood, E. AU - Hogg, R. S. AU - Yip, B. AU - Moore, D. AU - Harrigan, P. R. AU - Montaner, J. S. PY - 2006 DA - 2006// TI - Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl JO - AIDS. VL - 20 UR - https://doi.org/10.1097/01.aids.0000226951.49353.ed DO - 10.1097/01.aids.0000226951.49353.ed ID - Wood2006 ER - TY - JOUR AU - Stephan, C. AU - Hill, A. AU - Sawyer, W. AU - Delft, Y. AU - Moecklinghoff, C. PY - 2013 DA - 2013// TI - Impact of baseline HIV-1 RNA levels on initial highly active antiretroviral therapy outcome: a meta-analysis of 12,370 patients in 21 clinical trials JO - HIV Med VL - 14 UR - https://doi.org/10.1111/hiv.12004 DO - 10.1111/hiv.12004 ID - Stephan2013 ER - TY - JOUR AU - Raffi, F. AU - Hanf, M. AU - Ferry, T. AU - Khatchatourian, L. AU - Joly, V. AU - Pugliese, P. PY - 2017 DA - 2017// TI - Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen JO - J Antimicrob Chemother VL - 72 UR - https://doi.org/10.1093/jac/dkx300 DO - 10.1093/jac/dkx300 ID - Raffi2017 ER - TY - JOUR AU - Santoro, M. M. AU - Armenia, D. AU - Alteri, C. AU - Flandre, P. AU - Calcagno, A. AU - Santoro, M. PY - 2013 DA - 2013// TI - Impact of pre-therapy viral load on virological response to modern first-line HAART JO - Antivir Ther VL - 18 UR - https://doi.org/10.3851/IMP2531 DO - 10.3851/IMP2531 ID - Santoro2013 ER - TY - JOUR AU - Biagio, A. AU - Rusconi, S. AU - Marzocchetti, A. AU - Signori, A. AU - Schiavetti, I. AU - Bruzzone, B. PY - 2014 DA - 2014// TI - The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy JO - J Med Virol VL - 86 UR - https://doi.org/10.1002/jmv.24017 DO - 10.1002/jmv.24017 ID - Biagio2014 ER - TY - STD TI - EACS Guidelines version 8.0, October 2015 http://www.eacsociety.org/files/guidelines_8.0-english-revised_20160610.pdf. Accessed 19 Jun 2020. UR - http://www.eacsociety.org/files/guidelines_8.0-english-revised_20160610.pdf ID - ref11 ER - TY - STD TI - World Health Organization. Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2018 (WHO/CDS/HIV/18.51). Licence: CC BY-NC-SA 3.0 IGO. https://apps.who.int/iris/bitstream/handle/10665/277395/WHO-CDS-HIV-18.51-eng.pdf?ua=1. Accessed 19 Jun 2020. UR - https://apps.who.int/iris/bitstream/handle/10665/277395/WHO-CDS-HIV-18.51-eng.pdf?ua=1 ID - ref12 ER - TY - STD TI - AIDS and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association;Chinese Center for Disease Control and Prevention. Chinese guidelines for diagnosis and treatment of HIV/AIDS (2018). Zhonghua Nei Ke Za Zhi. 2018;57(12):867–84. ID - ref13 ER - TY - JOUR AU - Luo, L. AU - Wang, N. AU - Yue, Y. AU - Han, Y. AU - Lv, W. AU - Liu, Z. PY - 2019 DA - 2019// TI - The effects of antiretroviral therapy initiation time on HIV reservoir size in Chinese chronically HIV infected patients: a prospective, multi-site cohort study JO - BMC Infect Dis VL - 19 UR - https://doi.org/10.1186/s12879-019-3847-0 DO - 10.1186/s12879-019-3847-0 ID - Luo2019 ER - TY - JOUR AU - Li, T. AU - Guo, F. AU - Li, Y. AU - Zhang, C. AU - Han, Y. AU - Lye, W. PY - 2014 DA - 2014// TI - An antiretroviral regimen containing 6 months of stavudine followed by long-term zidovudine for first-line HIV therapy is optimal in resource-limited settings: a prospective, multicenter study in China JO - Chin Med J VL - 127 ID - Li2014 ER - TY - STD TI - EACS Guidelines version 9.1, October 2018. 2018. http://www.eacsociety.org/files/2018_guidelines-9.1-english.pdf. Accessed 19 Jun 2020. UR - http://www.eacsociety.org/files/2018_guidelines-9.1-english.pdf ID - ref16 ER - TY - STD TI - Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. USA: Department of Health and Human Services; 2019. Available at https://files.aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf. Accessed 19 Jun 2020. UR - https://files.aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf ID - ref17 ER - TY - JOUR AU - Fleming, J. AU - Mathews, W. C. AU - Rutstein, R. M. AU - Aberg, J. AU - Somboonwit, C. AU - Cheever, L. W. PY - 2019 DA - 2019// TI - Low-level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy JO - AIDS. VL - 33 UR - https://doi.org/10.1097/QAD.0000000000002306 DO - 10.1097/QAD.0000000000002306 ID - Fleming2019 ER - TY - STD TI - Kanters S JJ, Zoratti M, Forrest J, Humphries B, Campbell J. Web Annex B. Systematic literature review and network meta-analysis assessing first-line antiretroviral treatments In: Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2018 (WHO/CDS/HIV/18.25). Licence: CC BY-NC-SA 3.0 IGO. ID - ref19 ER - TY - JOUR AU - Vitoria, M. AU - Ford, N. AU - Clayden, P. AU - Pozniak, A. L. AU - Hill, A. M. PY - 2017 DA - 2017// TI - When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO think tank JO - Curr Opin HIV AIDS VL - 12 UR - https://doi.org/10.1097/COH.0000000000000380 DO - 10.1097/COH.0000000000000380 ID - Vitoria2017 ER - TY - JOUR AU - Peng, S. AU - Tafazzoli, A. AU - Dorman, E. AU - Rosenblatt, L. AU - Villasis-Keever, A. AU - Sorensen, S. PY - 2015 DA - 2015// TI - Cost-effectiveness of DTG + ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States JO - J Med Econ VL - 18 UR - https://doi.org/10.3111/13696998.2015.1046878 DO - 10.3111/13696998.2015.1046878 ID - Peng2015 ER - TY - JOUR AU - Pialoux, G. AU - Marcelin, A. G. AU - Cawston, H. AU - Guilmet, C. AU - Finkielsztejn, L. AU - Laurisse, A. PY - 2018 DA - 2018// TI - Cost-effectiveness of dolutegravir/abacavir/lamivudine in HIV-1 treatment-naive (TN) patients in France JO - Expert Rev Pharmacoecon Outcomes Res VL - 18 UR - https://doi.org/10.1080/14737167.2017.1359542 DO - 10.1080/14737167.2017.1359542 ID - Pialoux2018 ER - TY - JOUR AU - Peng, S. AU - Tafazzoli, A. AU - Dorman, E. AU - Rosenblatt, L. AU - Villasis-Keever, A. AU - Sorensen, S. PY - 2014 DA - 2014// TI - Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States JO - J Int AIDS Soc VL - 17 UR - https://doi.org/10.7448/IAS.17.4.19605 DO - 10.7448/IAS.17.4.19605 ID - Peng2014 ER - TY - JOUR AU - Cain, L. E. AU - Phillips, A. AU - Lodi, S. AU - Sabin, C. AU - Bansi, L. AU - Justice, A. PY - 2012 DA - 2012// TI - The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study JO - AIDS. VL - 26 ID - Cain2012 ER - TY - JOUR AU - Currier, J. AU - Averitt Bridge, D. AU - Hagins, D. AU - Zorrilla, C. D. AU - Feinberg, J. AU - Ryan, R. PY - 2010 DA - 2010// TI - Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial JO - Ann Intern Med VL - 153 UR - https://doi.org/10.7326/0003-4819-153-6-201009210-00002 DO - 10.7326/0003-4819-153-6-201009210-00002 ID - Currier2010 ER - TY - JOUR AU - Squires, K. E. AU - Young, B. AU - Santiago, L. AU - Dretler, R. H. AU - Walmsley, S. L. AU - Zhao, H. H. PY - 2017 DA - 2017// TI - Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks JO - HIV AIDS (Auckl) VL - 9 ID - Squires2017 ER - TY - JOUR AU - Squires, K. AU - Bekker, L. G. AU - Katlama, C. AU - Yazdanpanah, Y. AU - Zhou, Y. AU - Rodgers, A. J. PY - 2017 DA - 2017// TI - Influence of sex/gender and race on responses to raltegravir combined with tenofovir-emtricitabine in treatment-naive human immunodeficiency virus-1 infected patients: pooled analyses of the STARTMRK and QDMRK studies JO - Open Forum Infect Dis VL - 4 UR - https://doi.org/10.1093/ofid/ofw047 DO - 10.1093/ofid/ofw047 ID - Squires2017 ER - TY - JOUR AU - Soon, G. G. AU - Min, M. AU - Struble, K. A. AU - Chan-Tack, K. M. AU - Hammerstrom, T. AU - Qi, K. PY - 2012 DA - 2012// TI - Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008) JO - AIDS Patient Care STDs VL - 26 UR - https://doi.org/10.1089/apc.2011.0278 DO - 10.1089/apc.2011.0278 ID - Soon2012 ER - TY - JOUR AU - Matthews, L. T. AU - Giddy, J. AU - Ghebremichael, M. AU - Hampton, J. AU - Guarino, A. J. AU - Ewusi, A. PY - 2011 DA - 2011// TI - A risk-factor guided approach to reducing lactic acidosis and hyperlactatemia in patients on antiretroviral therapy JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0018736 DO - 10.1371/journal.pone.0018736 ID - Matthews2011 ER - TY - JOUR AU - Scully, E. P. PY - 2018 DA - 2018// TI - Sex differences in HIV infection JO - Curr HIV/AIDS Rep VL - 15 UR - https://doi.org/10.1007/s11904-018-0383-2 DO - 10.1007/s11904-018-0383-2 ID - Scully2018 ER - TY - JOUR AU - Gandhi, R. T. AU - Spritzler, J. AU - Chan, E. AU - Asmuth, D. M. AU - Rodriguez, B. AU - Merigan, T. C. PY - 2006 DA - 2006// TI - Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384 JO - J Acquir Immune Defic Syndr VL - 42 UR - https://doi.org/10.1097/01.qai.0000226789.51992.3f DO - 10.1097/01.qai.0000226789.51992.3f ID - Gandhi2006 ER - TY - JOUR AU - Luca, A. AU - Bugarini, R. AU - Lepri, A. C. AU - Puoti, M. AU - Girardi, E. AU - Antinori, A. PY - 2002 DA - 2002// TI - Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects JO - Arch Intern Med VL - 162 UR - https://doi.org/10.1001/archinte.162.18.2125 DO - 10.1001/archinte.162.18.2125 ID - Luca2002 ER - TY - JOUR AU - Chun, H. M. AU - Mesner, O. AU - Thio, C. L. AU - Bebu, I. AU - Macalino, G. AU - Agan, B. K. PY - 2014 DA - 2014// TI - HIV outcomes in hepatitis B virus coinfected individuals on HAART JO - J Acquir Immune Defic Syndr VL - 66 UR - https://doi.org/10.1097/QAI.0000000000000142 DO - 10.1097/QAI.0000000000000142 ID - Chun2014 ER - TY - JOUR AU - Marcus, J. L. AU - Leyden, W. A. AU - Chao, C. R. AU - Xu, L. AU - Quesenberry, C. P. AU - Tien, P. C. PY - 2015 DA - 2015// TI - Differences in response to antiretroviral therapy by sex and hepatitis C infection status JO - AIDS Patient Care STDs VL - 29 UR - https://doi.org/10.1089/apc.2015.0040 DO - 10.1089/apc.2015.0040 ID - Marcus2015 ER - TY - JOUR AU - Malagnino, V. AU - Cerva, C. AU - Maffongelli, G. AU - Teti, E. AU - Foroghi Biland, L. AU - Cesta, N. PY - 2019 DA - 2019// TI - HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy JO - Sci Rep VL - 9 UR - https://doi.org/10.1038/s41598-019-46976-1 DO - 10.1038/s41598-019-46976-1 ID - Malagnino2019 ER - TY - JOUR AU - Portocarrero Nunez, J. A. AU - Gonzalez-Garcia, J. AU - Berenguer, J. AU - Gallego, M. J. V. AU - Loyarte, J. A. I. AU - Metola, L. PY - 2018 DA - 2018// TI - Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients JO - Medicine (Baltimore) VL - 97 UR - https://doi.org/10.1097/MD.0000000000012238 DO - 10.1097/MD.0000000000012238 ID - Portocarrero Nunez2018 ER - TY - JOUR AU - Orrell, C. AU - Cohen, K. AU - Leisegang, R. AU - Bangsberg, D. R. AU - Wood, R. AU - Maartens, G. PY - 2017 DA - 2017// TI - Comparison of six methods to estimate adherence in an ART-naive cohort in a resource-poor setting: which best predicts virological and resistance outcomes? JO - AIDS Res Ther VL - 14 UR - https://doi.org/10.1186/s12981-017-0138-y DO - 10.1186/s12981-017-0138-y ID - Orrell2017 ER - TY - JOUR AU - Su, Y. AU - Zhang, F. AU - Liu, H. AU - Smith, M. K. AU - Zhu, L. AU - Wu, J. PY - 2014 DA - 2014// TI - The prevalence of HIV-1 drug resistance among antiretroviral treatment naive individuals in mainland China: a meta-analysis JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0110652 DO - 10.1371/journal.pone.0110652 ID - Su2014 ER - TY - JOUR AU - McCluskey, S. M. AU - Siedner, M. J. AU - Marconi, V. C. PY - 2019 DA - 2019// TI - Management of virologic failure and HIV drug resistance JO - Infect Dis Clin N Am VL - 33 UR - https://doi.org/10.1016/j.idc.2019.05.004 DO - 10.1016/j.idc.2019.05.004 ID - McCluskey2019 ER -